← Eichor
Study identifier: NCT06453291 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Assessment of Different Clinical Techniques to Treat Patients With Chronic Low Back Pain

Condition: Chronic Low Back Pain (CLBP)  ·  Sponsor: Iffat Anwar Medical Complex

PhaseNA
Planned participants100
Who can joinAll sexes, 40 Years to 60 Years
Healthy volunteersYes

About this study

This clinical trial aims to assess the effectiveness of different clinical techniques in treating patients with chronic low back pain (CLBP). Two test groups will be included: one receiving conventional therapy (NSAIDs and other physical therapy techniques) and the other receiving a combination of neuromodulation and platelet-rich plasma (PRP) therapy. Chronic pain, persisting for more than three months, inhibits natural pathways like GABA and promotes excitatory pathways, leading to increased inflammation. The study hypothesizes that neuromodulation via the dorsal root ganglion (DRG) and PRP therapy will provide superior pain relief and functional improvement compared to conventional therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Shahzad Anwar, MBBS, DOM  ·  +923009400049  ·  shahzadtirmzi@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Iffat Anwar Medical ComplexLahore, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06453291